Nicorandil Zydus (Nicorandil)

Nicorandil combines two mechanisms: it donates nitric oxide, which activates guanylate cyclase and raises cyclic GMP levels, leading to smooth‑muscle relaxation; and it opens ATP‑sensitive potassium channels, hyper‑polarising vascular cells. Together these actions produce coronary and peripheral vasodilation, lowering myocardial oxygen consumption.

The appropriate dose of Nicorandil is determined by the prescribing clinician based on the patient’s clinical condition, response, and tolerance. Physicians typically start with a low dose and may adjust it gradually to achieve optimal angina control while monitoring for side effects.

Safety data for Nicorandil during pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any special handling), and necessary import documentation.

Nicorandil differs from traditional nitrates by also opening potassium channels, offering a dual vasodilatory effect. This can provide better symptom control in patients who are tolerant to nitrates alone. Compared with beta‑blockers or calcium‑channel blockers, Nicorandil primarily reduces preload and afterload rather than heart rate, making it a useful adjunct or alternative in certain clinical scenarios.

Nicorandil tablets should be stored at ambient temperature, below 25 °C. Keep the medication in its original container, protect it from moisture and direct sunlight, and ensure the packaging remains tightly closed to maintain product stability.

Nicorandil is taken orally, usually as a tablet. Patients should swallow the tablet whole with a glass of water, unless otherwise directed by their healthcare provider. It is typically taken with or without food, following the dosing schedule prescribed by the clinician.

The most serious risks include severe hypotension, which can cause dizziness or fainting; rare cases of myocardial infarction; gastrointestinal ulceration; and severe allergic reactions such as Stevens‑Johnson syndrome or anaphylaxis. Prompt medical attention is required if any of these serious symptoms occur.

Nicorandil is contraindicated in patients with severe hypotension, recent myocardial infarction, unstable angina, or known hypersensitivity to the drug. Caution is also advised for individuals with significant liver disease, as well as for pregnant or breastfeeding women when safer alternatives are available.